Côd QR

Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization

Jonathan Corren,1 David J Jackson,2,3 Thomas B Casale,4 Larry Borish,5,6 Klaus F Rabe,7,8 William W Busse,9 Jorge F Maspero,10 Daniel J Jackson,11 Nadia Daizadeh,12 Arman Altincatal,12 Amr Radwan,13 Angela Khodzhayev,13 Michel Djandji,12 Juby A Jacob-Nara,12,14 Paul J Rowe,14 Yamo Deniz13 1David Gef...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Corren J, Jackson DJ, Casale TB, Borish L, Rabe KF, Busse WW, Maspero JF, Daizadeh N, Altincatal A, Radwan A, Khodzhayev A, Djandji M, Jacob-Nara JA, Rowe PJ, Deniz Y
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Dove Medical Press 2023-03-01
Cyfres:Journal of Asthma and Allergy
Pynciau:
dupilumab
allergic asthma
type 2 asthma
perennial aeroallergen
Mynediad Ar-lein:https://www.dovepress.com/dupilumab-efficacy-in-patients-with-uncontrolled-moderate-to-severe-ty-peer-reviewed-fulltext-article-JAA
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg